RecruitingNCT05577585
Ketamine or midazolam for OCD: stress and cognition
About this title
Read the official source — NCT05577585Medication studyAges 18+Austria
Understand this study
Who could participate?
This study is for people with OCD. Listed age limits: from 18 years. Other eligibility criteria apply.
- Listed locations
- ViennaSee all locations and recruitment
What to know before participating
A point to clarify
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
Study start dateStarted: October 1, 2022
- Recruitment status
- Recruiting
- Enrollment listed in the registry
- 60
- Sponsor
- Medical University of Vienna
- Sponsor type
- University
- Study type
- Drug
- Intervention type
- Drug, Other
- Locations
- Austria
- Age range
- Over 18 Years
- Official registry ID
- NCT05577585
- Official title
Show the full official title
Ketamine Therapy in Obsessive-compulsive Disorder and Its Effects on Neuropsychological Function Under Stress in a Cross-over Trial
Recruitment & locations
Currently recruitingA study may be recruiting, but some locations may no longer be accepting participants. Confirm availability with the research team.
Vienna
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is Medical University of Vienna, a university.
Does this study involve medication?
Yes. The study involves medication, including Ketamine 50 MG/ML Blinded, Midazolam and Ketamine 50 MG/ML Open Label.
Who can participate?
This study is for people with OCD. Listed age limits: from 18 years. Other eligibility criteria apply.
Is this study still recruiting?
The registry lists this study as recruiting.
